Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study-Reference-Cited by-同舟云学术

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

Published:2014-06 Issue:6 Volume:170 Page:1341-1349
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Kanwar A.J.¹,Vinay K.¹,Sawatkar G.U.¹,Dogra S.¹,Minz R.W.²,Shear N.H.³,Koga H.⁴,Ishii N.⁴,Hashimoto T.⁴

Affiliation:

1. Department of Dermatology, Venereology and Leprology

2. Department of Immunopathology; Postgraduate Institute of Medical Education and Research; Chandigarh 160012 India

3. Department of Dermatology; Sunnybrook Health Sciences Centre; University of Toronto; Toronto ON Canada

4. Department of Dermatology; Kurume University School of Medicine; Kurume University Institute of Cutaneous Cell Biology; 67 Asahimachi Kurume Fukuoka 830-0011 Japan

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.12972/fullpdf

Reference32 articles.

1. Rituximab in severe pemphigus;Schmidt;Ann N Y Acad Sci,2009

2. Efficacy and safety of rituximab treatment in Indian pemphigus patients;Kanwar;J Eur Acad Dermatol Venereol,2013

3. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up;Reguiai;J Am Acad Dermatol,2012

4. Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris;Craythorne;J Am Acad Dermatol,2011

5. Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?;Nigam;J Drugs Dermatol,2012

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunobullous Diseases;Rook's Textbook of Dermatology;2024-03-19

2. The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study;Journal of Dermatological Treatment;2024-01-22

3. Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?;Antibodies;2024-01-05

4. Biologic Agents;Contemporary Dental Pharmacology;2024

5. Clinical observation of different doses of rituximab for the treatment of severe pemphigus: A single-center prospective cohort study;Journal of the American Academy of Dermatology;2023-02